United States · FDA National Drug Code directory
Fiasp
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0169-3204_133d5f6e-b40f-47b6-ab47-10dc37114d79
- Product NDC
- 0169-3204
- Form
- INJECTION, SOLUTION
- Composition / generic term
- insulin aspart injection
- Labeler
- Novo Nordisk
- Marketing category
- BLA
- Marketing start / end (source format)
- 20171020
- Source listing expiry
- 20261231
Source-listed ingredients
- INSULIN ASPART — 100 [iU]/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 5 SYRINGE, PLASTIC in 1 CARTON (0169-3204-15) / 3 mL in 1 SYRINGE, PLASTIC · 0169-3204-15
- 1 SYRINGE, PLASTIC in 1 CARTON (0169-3204-97) / 3 mL in 1 SYRINGE, PLASTIC (0169-3204-90) · 0169-3204-97
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →